Research Topics
| Amy L OlsonSummaryAffiliation: University of Colorado Health Sciences Center Country: USA Publications
| Collaborators
|
Detail Information
Publications
A 50-year-old man with skin lesions and multiple pulmonary nodulesAmy L Olson
Denver Veterans Affairs Medical Center, Eastern Colorado Health Care System, Denver, USA
Chest 125:2322-7. 2004- The obesity hypoventilation syndromeAmy L Olson
University of Colorado Health Sciences Center, Division of Pulmonary Sciences and Critical Care Medicine, Denver, 80262, USA
Am J Med 118:948-56. 2005..This article reviews current definitions of the obesity hypoventilation syndrome, clinical presentation and diagnosis, present understanding of the pathophysiology, and treatment options... - A 63-year-old man with a persistent pulmonary infiltrate and pleural effusionAmy L Olson
Division of Pulmonary Sciences and Critical Care Medicine, University of Colorado Health Sciences Center, 4200 East Ninth Ave, C272, Denver, CO 80262, USA
Chest 130:1929-34. 2006 - Mortality from pulmonary fibrosis increased in the United States from 1992 to 2003Amy L Olson
Division of Pulmonary Sciences and Critical Care Medicine, University of Colorado Health Sciences Center, Denver Colorado 80262, USA
Am J Respir Crit Care Med 176:277-84. 2007..From the late 1970s to the early 1990s, studies found that mortality rates for pulmonary fibrosis were increasing. Recent data for mortality from pulmonary fibrosis are unavailable... 
Seasonal variation: mortality from pulmonary fibrosis is greatest in the winterAmy L Olson
Division of Pulmonary Sciences and Critical Care Medicine, University of Colorado Health Sciences Center, Denver, CO 80262, USA
Chest 136:16-22. 2009..Our objective was to determine if mortality rates from IPF and/or PF of any cause exhibit seasonal variation...- Acute exacerbations of fibrotic hypersensitivity pneumonitis: a case seriesAmy L Olson
Division of Pulmonary Sciences and Critical Care Medicine, University of Colorado Health Sciences Center, 4200 East Ninth Ave, C272, Denver, CO 80262, USA
Chest 134:844-50. 2008..While best described in patients with IPF, they have also been reported in patients with other forms of interstitial lung disease. We sought to determine if this same phenomenon occurs in patients with hypersensitivity pneumonitis (HP)... 
Ethnic and racial differences in the presence of idiopathic pulmonary fibrosis at deathJeffrey J Swigris
Autoimmune Lung Center and Interstitial Lung Disease Program, National Jewish Health, Denver, CO 80206, USA
Respir Med 106:588-93. 2012..In studies of idiopathic pulmonary fibrosis (IPF), whites makeup the vast majority of subjects. Whether ethnic/racial differences in idiopathic pulmonary fibrosis occur in the general population is unknown...- Rheumatoid arthritis-interstitial lung disease-associated mortalityAmy L Olson
Division of Pulmonary and Critical Care Medicine, Interstitial Lung Disease Program, and Autoimmune Lung Center, National Jewish Health, Denver, Colorado, USA
Am J Respir Crit Care Med 183:372-8. 2011..Mortality rates from rheumatoid arthritis-associated interstitial lung disease (RA-ILD) are largely unknown... - A detailed evaluation of acute respiratory decline in patients with fibrotic lung disease: aetiology and outcomesTristan J Huie
University of Colorado Denver, Division of Pulmonary Sciences and Critical Care Medicine, Aurora, Colorado 80045, USA
Respirology 15:909-17. 2010..A comprehensive diagnostic evaluation is recommended for all patients with fibrotic lung disease and acute respiratory decompensation. However, the effect on clinical outcomes of this evaluation remains unknown... - Obstructive sleep apnea does not promote esophageal reflux in fibrosing interstitial lung diseaseManju Pillai
Sleep Medicine Program, National Jewish Health, Denver, CO, USA
Respir Med 106:1033-9. 2012..We conducted this study to test our hypothesis that, in patients with fILD, OSA would exacerbate diaphragm/LES dysfunction and increase the propensity for-and severity of - GER... - Lung disease with anti-CCP antibodies but not rheumatoid arthritis or connective tissue diseaseAryeh Fischer
Autoimmune Lung Center, National Jewish Health, Denver, CO 80206, USA
Respir Med 106:1040-7. 2012..We sought to characterize a novel cohort of patients with lung disease, anti-cyclic citrullinated peptide (CCP) antibody positivity, without rheumatoid arthritis (RA) or other connective tissue disease (CTD)... - Increased risk of pulmonary embolism among US decedents with sarcoidosis from 1988 to 2007Jeffrey J Swigris
Autoimmune Lung Center and Interstitial Lung Disease Program, National Jewish Health, Southside Building, Office No G011, 1400 Jackson St, Denver, CO 80206, USA
Chest 140:1261-6. 2011..A recently published report from the United Kingdom suggested an association between sarcoidosis and pulmonary embolism (PE). We sought to examine whether this association was present among US decedents with sarcoidosis... - Idiopathic pulmonary fibrosis: diagnosis and epidemiologyAmy L Olson
Interstitial Lung Disease Program, Division of Pulmonary and Critical Care Medicine, Autoimmune Lung Center, National Jewish Health, Denver, CO 80206, USA
Clin Chest Med 33:41-50. 2012..This article summarizes the approach to diagnosing IPF and reviews epidemiologic data on IPF... - Sarcoidosis-related mortality in the United States from 1988 to 2007Jeffrey J Swigris
Autoimmune Lung Center and Interstitial Lung Disease Program, National Jewish Health, Denver, CO 80206, USA
Am J Respir Crit Care Med 183:1524-30. 2011..Objectives: To examine mortality rates and underlying causes of death among United States decedents with sarcoidosis from 1988-2007... - Connective tissue disease-associated lung diseaseAmy L Olson
Autoimmune and Interstitial Lung Disease Program, National Jewish Health, 1400 Jackson Street, Denver, CO 80206, USA
Immunol Allergy Clin North Am 32:513-36. 2012..A concise review of the many pulmonary manifestations of each specific CTD is provided, and particular emphasis is placed on CTD-associated interstitial lung disease... - Eosinophilic lung diseasesEvans R Fernandez Perez
Interstitial Lung Disease Program, Autoimmune Lung Center, National Jewish Health, Denver, CO 80206, USA
Med Clin North Am 95:1163-87. 2011..This review focuses on the clinical features, general diagnostic workup, and management of the eosinophilic lung diseases... - Mycophenolate mofetil is safe, well tolerated, and preserves lung function in patients with connective tissue disease-related interstitial lung diseaseJeffrey J Swigris
Autoimmune Kung Center, Interstitial Lung Disease Program, National Jewish Medical and Research Center, 1400 Jackson St, Molly Blank J229, Denver, CO 80206, USA
Chest 130:30-6. 2006..In this study, our objectives were to examine the safety and tolerability of mycophenolate mofetil (MMF) and to determine its impact on lung function in patients with CTD-ILD... - Heart rate recovery after six-minute walk test predicts pulmonary hypertension in patients with idiopathic pulmonary fibrosisJeffrey J Swigris
Interstitial Lung Disease Program and Autoimmune Lung Center, National Jewish Health, Denver, Colorado 80206, USA
Respirology 16:439-45. 2011..In patients with IPF, we sought to validate that abnormal heart rate recovery at 1 min (HRR1) after six-minute walk test (6MWT) predicts mortality and to explore the relationship between abnormal HRR1 and pulmonary hypertension (PH)...